Plasmatic MicroRNAs and Treatment Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer: A Hospital-Based Cohort Study and In Silico Analysis

Prostate cancer (PCa) is one of the most common malignancies among men worldwide. Inevitably, all advanced PCa patients develop metastatic castration-resistant prostate cancer (mCRPC), an aggressive phase of the disease. Treating mCRPC is challenging, and prognostic tools are needed for disease mana...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Jani, Tavares, Valéria, Afonso, Ana, Garcia, Juliana, Cerqueira, Fátima, Medeiros, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219330/
https://www.ncbi.nlm.nih.gov/pubmed/37240449
http://dx.doi.org/10.3390/ijms24109101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219330/
https://www.ncbi.nlm.nih.gov/pubmed/37240449
http://dx.doi.org/10.3390/ijms24109101

Ejemplares similares